Skip to main content
Erschienen in: International Ophthalmology 4/2016

02.12.2015 | Original Paper

Management of iatrogenic crystalline lens injury occurred during intravitreal injection

verfasst von: Gurkan Erdogan, Betul Onal Gunay, Cihan Unlu, Murat Gunay, Ahmet Ergin

Erschienen in: International Ophthalmology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

To evaluate the approach to management of iatrogenic crystalline lens injury occurred during intravitreal injection (IVI). The patients who were managed operatively or followed-up without intervention after the iatrogenic lens injury due to IVI were included in the study. Capsular breaks remained either quiescent or resulted in cataract formation in the patients with inadvertent crystalline lens capsule damage. Phacoemulsification surgery was performed in patients with cataract formation with lower fluidic settings. A total of 9 cases included in the study. Seven cases underwent phacoemulsification with intraocular lens implantation. Two cases remained as quiescent lens injury during the follow-up. In 2 cases, dislocation of lens fragments occurred during phacoemulsification where pars plana vitrectomy was performed at the same session. After iatrogenic crystalline lens injury, capsular damage could remain quiescent or progress to cataract formation. Although phacoemulsification surgery can be performed with appropriate parameters, lens fragment dislocation can be observed in cases with traumatic lens damage secondary to IVI.
Literatur
1.
Zurück zum Zitat Meyer CH, Rodrigues EB, Michels S, Mennel S, Schmidt JC, Helb HM, Hager A, Martinazzo M, Farah ME (2010) Incidence of damage to the crystalline lens during intravitreal injections. J Ocul Pharmacol Ther 26:491–495CrossRefPubMed Meyer CH, Rodrigues EB, Michels S, Mennel S, Schmidt JC, Helb HM, Hager A, Martinazzo M, Farah ME (2010) Incidence of damage to the crystalline lens during intravitreal injections. J Ocul Pharmacol Ther 26:491–495CrossRefPubMed
2.
Zurück zum Zitat Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR (2004) VEGF inhibition study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805–2816CrossRefPubMed Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR (2004) VEGF inhibition study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805–2816CrossRefPubMed
3.
Zurück zum Zitat Shima C, Sakaguchi H, Gomi F, Kamei M, Ikuno Y, Oshima Y, Sawa M, Tsujikawa M, Kusaka S, Tano Y (2008) Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86:372–376CrossRefPubMed Shima C, Sakaguchi H, Gomi F, Kamei M, Ikuno Y, Oshima Y, Sawa M, Tsujikawa M, Kusaka S, Tano Y (2008) Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol 86:372–376CrossRefPubMed
4.
Zurück zum Zitat Fung AE, Rosenfeld PJ, Reichel E (2006) The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90:1344–1349CrossRefPubMedPubMedCentral Fung AE, Rosenfeld PJ, Reichel E (2006) The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90:1344–1349CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Ladas ID, Karagiannis DA, Rouvas AA, Kotsolis AI, Liotsou A, Vergados I (2009) Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2000 injections. Retina 29:313–318CrossRefPubMed Ladas ID, Karagiannis DA, Rouvas AA, Kotsolis AI, Liotsou A, Vergados I (2009) Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2000 injections. Retina 29:313–318CrossRefPubMed
6.
Zurück zum Zitat Jonas JB, Spandau UH, Schlichtenbrede F (2008) Short-term complications of intravitreal injections of triamcinolone and bevacizumab. Eye 22:590–591CrossRefPubMed Jonas JB, Spandau UH, Schlichtenbrede F (2008) Short-term complications of intravitreal injections of triamcinolone and bevacizumab. Eye 22:590–591CrossRefPubMed
7.
Zurück zum Zitat Khalifa YM, Pantanelli SM (2011) Quiescent posterior capsule trauma after intravitreal injection: implications for the cataract surgeon. J Cataract Refract Surg 37:1364CrossRefPubMed Khalifa YM, Pantanelli SM (2011) Quiescent posterior capsule trauma after intravitreal injection: implications for the cataract surgeon. J Cataract Refract Surg 37:1364CrossRefPubMed
8.
Zurück zum Zitat Saeed MU, Prasad S (2009) Management of cataract caused by inadvertent capsule penetration during intravitreal injection of ranibizumab. J Cataract Refract Surg 35:1857–1859CrossRefPubMed Saeed MU, Prasad S (2009) Management of cataract caused by inadvertent capsule penetration during intravitreal injection of ranibizumab. J Cataract Refract Surg 35:1857–1859CrossRefPubMed
Metadaten
Titel
Management of iatrogenic crystalline lens injury occurred during intravitreal injection
verfasst von
Gurkan Erdogan
Betul Onal Gunay
Cihan Unlu
Murat Gunay
Ahmet Ergin
Publikationsdatum
02.12.2015
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 4/2016
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-015-0156-5

Weitere Artikel der Ausgabe 4/2016

International Ophthalmology 4/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.